Daisuke Ogawa Selected Research

Daisuke Ogawa Research Topics

Disease

25	Diabetic Nephropathies (Diabetic Nephropathy) 02/2021 - 09/2002
18	Neoplasms (Cancer) 04/2024 - 01/2012
11	Type 2 Diabetes Mellitus (MODY) 04/2018 - 04/2006
9	Albuminuria 01/2019 - 02/2007
7	Glioblastoma (Glioblastoma Multiforme) 11/2023 - 01/2012
7	Glioma (Gliomas) 07/2023 - 01/2012
7	Obesity 02/2016 - 10/2007
6	Inflammation (Inflammations) 01/2014 - 04/2003
5	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 03/2018 - 01/2008
5	Body Weight (Weight, Body) 01/2016 - 02/2003
5	Hypertrophy 01/2014 - 10/2003
4	Fibrosis (Cirrhosis) 01/2016 - 11/2012
4	Insulin Resistance 01/2013 - 10/2007
4	Wounds and Injuries (Trauma) 01/2013 - 11/2005
4	Proteinuria 01/2012 - 11/2002
3	Adenocarcinoma 04/2024 - 04/2020
3	Neoplasm Metastasis (Metastasis) 12/2023 - 12/2022
3	Infections 01/2020 - 11/2010
3	Hyperglycemia 01/2016 - 01/2014
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2014 - 02/2007
3	Atherosclerosis 03/2007 - 04/2005
3	Glomerulonephritis 01/2005 - 11/2002
2	Pancreatic Neoplasms (Pancreatic Cancer) 04/2024 - 04/2024
2	Cholangiocarcinoma 01/2024 - 04/2020
2	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 11/2023
2	Renal Insufficiency (Renal Failure) 02/2021 - 02/2010
2	Chronic Renal Insufficiency 04/2018 - 01/2018
2	Chronic Kidney Failure (Chronic Renal Failure) 04/2018 - 02/2010
2	Hypoxia (Hypoxemia) 07/2016 - 10/2014
2	Edema (Dropsy) 01/2015 - 07/2002
2	Diabetes Mellitus 03/2013 - 07/2002
2	Vascular System Injuries 03/2013 - 04/2006
2	Kidney Diseases (Kidney Disease) 01/2013 - 01/2012
2	Pain (Aches) 12/2012 - 06/2003
2	Hypertension (High Blood Pressure) 01/2012 - 02/2010
2	Olfactory Nerve Injuries 09/2008 - 01/2008
2	Ureteral Obstruction 01/2004 - 04/2003
2	Nephritis 12/2002 - 11/2002
1	Squamous Cell Carcinoma of Head and Neck 11/2023
1	Frailty 11/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023

Drug/Important Bio-Agent (IBA)

9	AlbuminsIBA 02/2021 - 10/2003
8	Blood Glucose (Blood Sugar)IBA 03/2018 - 06/2003
7	CreatinineIBA 02/2021 - 02/2010
7	Glucose (Dextrose)FDA LinkGeneric 03/2018 - 01/2013
6	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2013
6	Streptozocin (Streptozotocin)FDA Link 01/2014 - 02/2003
5	LigandsIBA 03/2013 - 11/2002
4	Proteins (Proteins, Gene)FDA Link 04/2018 - 01/2005
4	Small Interfering RNA (siRNA)IBA 10/2017 - 01/2012
4	CytokinesIBA 01/2015 - 10/2007
4	C-Reactive ProteinIBA 01/2015 - 06/2003
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2014 - 04/2006
4	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2014 - 04/2005
3	fluoromisonidazoleIBA 07/2023 - 10/2014
3	Polysaccharides (Glycans)IBA 01/2018 - 01/2005
3	Insulin (Novolin)FDA Link 01/2016 - 04/2006
3	MicroRNAs (MicroRNA)IBA 04/2015 - 09/2013
3	OsteopontinIBA 11/2012 - 10/2007
3	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2012 - 10/2003
3	Transforming Growth Factor beta (TGF-beta)IBA 04/2007 - 10/2003
3	SelectinsIBA 01/2005 - 11/2002
3	L-SelectinIBA 01/2004 - 11/2002
2	AntigensIBA 11/2023 - 07/2002
2	CarbohydratesIBA 11/2023 - 01/2014
2	Prorenin ReceptorIBA 01/2023 - 10/2017
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021 - 10/2017
2	LectinsIBA 01/2018 - 01/2013
2	Sucrose (Saccharose)IBA 02/2016 - 06/2015
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2016 - 01/2014
2	Hemoglobins (Hemoglobin)IBA 01/2016 - 01/2014
2	dapagliflozinIBA 01/2016 - 01/2014
2	Sodium-Glucose Transport ProteinsIBA 01/2016 - 01/2014
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2015 - 03/2013
2	Angiotensin Receptor AntagonistsIBA 12/2015 - 03/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015 - 10/2014
2	Endoplasmic Reticulum Chaperone BiPIBA 03/2013 - 11/2012
2	Telmisartan (Micardis)FDA Link 01/2013 - 01/2012
2	Liver X ReceptorsIBA 11/2012 - 04/2005
2	Pioglitazone (Actos)FDA Link 04/2012 - 04/2007
2	Angiotensin II Type 1 Receptor BlockersIBA 01/2012 - 03/2007
2	Imatinib Mesylate (Gleevec)FDA Link 04/2009 - 02/2007
2	Hyaluronic Acid (Hyaluronan)IBA 01/2005 - 11/2002
2	Therapeutic UsesIBA 01/2005 - 11/2002
2	P-SelectinIBA 01/2005 - 11/2002
2	Nitric Oxide Synthase (NO Synthase)IBA 12/2002 - 09/2002
1	Tumor Biomarkers (Tumor Markers)IBA 04/2024
1	Indicators and Reagents (Reagents)IBA 04/2024
1	SugarsIBA 11/2023
1	alloseIBA 11/2023

Therapy/Procedure

14	Therapeutics 12/2023 - 11/2002
4	Hepatectomy 01/2024 - 04/2020
3	Drug Therapy (Chemotherapy) 04/2024 - 01/2017
2	Radiotherapy 07/2023 - 07/2016
2	Decompression 01/2020 - 07/2019
2	Conservative Treatment 07/2019 - 11/2005
1	Neoadjuvant Therapy 04/2024
1	Aftercare (After-Treatment) 12/2023
1	Molecular Targeted Therapy 12/2023
1	Intraperitoneal Injections 11/2023